Adenocarcinoma of the Appendix - 170 Studies Found Status Study Completed Study Name: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer Condition: Malignant Ovarian Mixed Epithelial Tumor Ovarian Brenner Tumor Drug: TLR8 Agonist VTX-2337 Gi Completed Study Name: Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma Condition: Brenner Tumor Fallopian Tube Cancer Ovarian Clear Cell Date: 2003-05-06 Interventions: Drug: paclitaxel Given IV Active, not recruiting Study Name: Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condition: Malignant Ovarian Mixed Epithelial Tumor Ovarian Brenner Tumor Biological: Bevacizumab Given Completed Study Name: Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer Condition: Fallopian Tube Carcinoma Malignant Ovarian Mixed Epithelial Tumor Drug: Carboplatin Given IV Recruiting Study Name: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Condition: Ovarian Brenner Tumor Ovarian Carcinosarcoma Ovarian Clear Date: 2014-03-28 Interventions: Drug: Gemcitabine Hydrochloride Completed Study Name: A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condition: Fallopian Tube Carcinoma Malignant Ovarian Mixed Epithelial Tumor Biological: Urokinase-Derived Peptide A6 Suspended Study Name: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer Condition: Nausea and Vomiting Ovarian Brenner Tumor Ovarian Clear Ce Date: 2011-01-11 Interventions: Procedure: Adjuvant Therapy An Completed Study Name: Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin Condition: Brenner Tumor Fallopian Tube Cancer Ovarian Clear Cell Date: 2009-10-09 Interventions: Drug: belinostat Given IV Completed Study Name: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy Condition: Brenner Tumor Fallopian Tube Cancer Ovarian Clear Cell Date: 2007-04-25 Interventions: Biological: sargramostim Given Completed Study Name: Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer Condition: Chemotherapeutic Agent Toxicity Endometrial Adenocarcinoma Date: 2008-12-20 Interventions: Drug: Paclitaxel Given IV or i <<< Previous | Next >>>